Artivion

CryoLife is one of the world's leading contemporary medical device companies, providing preserved human tissues for cardiac and vascular surgeries, mechanical heart valves for aortic or mitral valve replacement, surgical adhesives and sealants, cardiac lasers for the treatment of refractory angina, as well as state-of-the-art technology and surgical training for adult and pediatric cardiovascular surgery. Since its establishment in 1984, it is estimated that CryoLife's products and tissues have been implanted in more than one million patients worldwide.On January 18, 2022, CryoLife announced its name change to Artivion.